In resource-poor countries such as Bangladesh, proven life-saving commodities for pregnant women have not been optimally examined, such as magnesium sulphate (MgSO4) to manage severe pre-eclampsia/eclampsia, use of anti-hypertensives to manage high blood pressure during pregnancy, aspirin prophylaxis for pregnant women at high risk of PE/E, as well as task shifting to lower health-worker cadres, and community involvement. There has been no systematic review of research and programming on PE/E prevention, early detection, and treatment in Bangladesh. With support from USAID, the Ending Eclampsia project has been expanding access to proven, underutilized interventions and commodities for PE/E prevention, early detection, and management, particularly expansion of MgSO4 access in several countries through primary health care (PHC) providers. In 2015, a landscaping analysis identified articles reporting PE/E burdens, common risk factors, incidence, adverse outcomes, and mortality rates; few studies, however, discuss implementation research (IR) for improving PE/E prevention, detection, and timely management, particularly within PHC facilities. Following a two-year intervention expanding MgSO4 provision through PHC providers in 12 subdistricts of Bangladesh, this endline report describes the IR conducted by the Population Council from 2015 to 2018.
Hossain, Sharif M.I., Shongkour Roy, Kanij Sultana, and Charlotte E. Warren. 2019. "Assessing the effect of a primary health care intervention for improving pre-eclampsia and eclampsia knowledge and practice in Bangladesh," Ending Eclampsia Endline Report. Washington, DC: Population Council.